Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Danesi

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Metabolism: Clinical and Experimental|August 1, 1996
The effects of the somatostatin analog octreotide on angiogenesis in vitroR Danesi, M Del Tacca
Transplantation Proceedings|April 28, 2004
Hematologic toxicity of immunosuppressive treatmentR Danesi, M Del Tacca
International Journal of Clinical Pharmacology Research|January 1, 1985
Clinical study on the efficacy of clofoctol in the treatment of infectious respiratory diseasesR Danesi, M Del Tacca
Transplantation Proceedings|April 28, 2004
Teratogenesis and immunosuppressive treatmentR Danesi, M Del Tacca
Journal of Pharmacological Methods|November 1, 1986
Measurement of the S alpha T segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the ratR Danesi, M Del Tacca, G Soldani
British Journal of Cancer|November 27, 2001
Pharmacogenetics of anticancer drugs in non-Hodgkin lymphomasL Loni, M Del Tacca, R Danesi
Journal of Environmental Radioactivity|December 26, 2002
Properties, use and health effects of depleted uranium (DU): a general overviewA Bleise, P R Danesi, W Burkart
Clinical Pharmacokinetics|October 8, 1999
Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancerR Danesi, P F Conte, M Del Tacca
Tumori|April 29, 2000
[Preclinical pharmacology and clinical uses of topotecan]M Del Tacca, A Di Paolo, R Danesi
Journal of Medicinal Chemistry|March 29, 1996
Geranylgeranyl diphosphate-based inhibitors of post-translational geranylgeranylation of cellular proteinsM Macchia, N Jannitti, G Gervasi, et al.
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Metabolism: Clinical and Experimental|August 1, 1996
The effects of the somatostatin analog octreotide on angiogenesis in vitroR Danesi, M Del Tacca
Transplantation Proceedings|April 28, 2004
Hematologic toxicity of immunosuppressive treatmentR Danesi, M Del Tacca
International Journal of Clinical Pharmacology Research|January 1, 1985
Clinical study on the efficacy of clofoctol in the treatment of infectious respiratory diseasesR Danesi, M Del Tacca
Transplantation Proceedings|April 28, 2004
Teratogenesis and immunosuppressive treatmentR Danesi, M Del Tacca
Journal of Pharmacological Methods|November 1, 1986
Measurement of the S alpha T segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the ratR Danesi, M Del Tacca, G Soldani
British Journal of Cancer|November 27, 2001
Pharmacogenetics of anticancer drugs in non-Hodgkin lymphomasL Loni, M Del Tacca, R Danesi
Journal of Environmental Radioactivity|December 26, 2002
Properties, use and health effects of depleted uranium (DU): a general overviewA Bleise, P R Danesi, W Burkart
Clinical Pharmacokinetics|October 8, 1999
Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancerR Danesi, P F Conte, M Del Tacca
Tumori|April 29, 2000
[Preclinical pharmacology and clinical uses of topotecan]M Del Tacca, A Di Paolo, R Danesi
Journal of Medicinal Chemistry|March 29, 1996
Geranylgeranyl diphosphate-based inhibitors of post-translational geranylgeranylation of cellular proteinsM Macchia, N Jannitti, G Gervasi, et al.
Pageof 16